
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Is Parkinson’s disease a lysosomal disorder?
Andrés D. Klein, Joseph R. Mazzulli
Brain (2018) Vol. 141, Iss. 8, pp. 2255-2262
Open Access | Times Cited: 152
Andrés D. Klein, Joseph R. Mazzulli
Brain (2018) Vol. 141, Iss. 8, pp. 2255-2262
Open Access | Times Cited: 152
Showing 1-25 of 152 citing articles:
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Mónica Gómez-Benito, Noelia Granado, Patricia García‐Sanz, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 317
Mónica Gómez-Benito, Noelia Granado, Patricia García‐Sanz, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 317
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine
Sara Bandrés‐Ciga, Mónica Díez-Fairén, Jonggeol Jeff Kim, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104782-104782
Open Access | Times Cited: 310
Sara Bandrés‐Ciga, Mónica Díez-Fairén, Jonggeol Jeff Kim, et al.
Neurobiology of Disease (2020) Vol. 137, pp. 104782-104782
Open Access | Times Cited: 310
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta Riboldi, Alessio Di Fonzo
Cells (2019) Vol. 8, Iss. 4, pp. 364-364
Open Access | Times Cited: 245
Giulietta Riboldi, Alessio Di Fonzo
Cells (2019) Vol. 8, Iss. 4, pp. 364-364
Open Access | Times Cited: 245
LRRK2 mediates tubulation and vesicle sorting from lysosomes
Luis Bonet‐Ponce, Alexandra Beilina, Chad D. Williamson, et al.
Science Advances (2020) Vol. 6, Iss. 46
Open Access | Times Cited: 208
Luis Bonet‐Ponce, Alexandra Beilina, Chad D. Williamson, et al.
Science Advances (2020) Vol. 6, Iss. 46
Open Access | Times Cited: 208
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Bilal R. Malik, Daniel C. Maddison, Gaynor A. Smith, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 157
Bilal R. Malik, Daniel C. Maddison, Gaynor A. Smith, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 157
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
Shared genetic risk loci between Alzheimer’s disease and related dementias, Parkinson’s disease, and amyotrophic lateral sclerosis
Michael Wainberg, Shea J. Andrews, Shreejoy J. Tripathy
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Michael Wainberg, Shea J. Andrews, Shreejoy J. Tripathy
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Danna Jennings, Sarah Huntwork‐Rodriguez, Maurits F. J. M. Vissers, et al.
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 386-398
Open Access | Times Cited: 45
Neuronal Soma-Derived Degradative Lysosomes Are Continuously Delivered to Distal Axons to Maintain Local Degradation Capacity
Tamar Farfel‐Becker, Joseph C. Roney, Xiu‐Tang Cheng, et al.
Cell Reports (2019) Vol. 28, Iss. 1, pp. 51-64.e4
Open Access | Times Cited: 130
Tamar Farfel‐Becker, Joseph C. Roney, Xiu‐Tang Cheng, et al.
Cell Reports (2019) Vol. 28, Iss. 1, pp. 51-64.e4
Open Access | Times Cited: 130
Tobacco smoking and the risk of Parkinson disease
Benjamin Mappin‐Kasirer, Hongchao Pan, Sarah Lewington, et al.
Neurology (2020) Vol. 94, Iss. 20
Open Access | Times Cited: 115
Benjamin Mappin‐Kasirer, Hongchao Pan, Sarah Lewington, et al.
Neurology (2020) Vol. 94, Iss. 20
Open Access | Times Cited: 115
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
Konstantin Senkevich, Ziv Gan‐Or
Parkinsonism & Related Disorders (2019) Vol. 73, pp. 60-71
Open Access | Times Cited: 109
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease
Kai-Jung Lin, Kai-Lieh Lin, Shang‐Der Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5312-5312
Open Access | Times Cited: 104
Kai-Jung Lin, Kai-Lieh Lin, Shang‐Der Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5312-5312
Open Access | Times Cited: 104
The Emerging Role of the Lysosome in Parkinson’s Disease
Alba Navarro-Romero, Marta Montpeyó, Marta Martínez‐Vicente
Cells (2020) Vol. 9, Iss. 11, pp. 2399-2399
Open Access | Times Cited: 102
Alba Navarro-Romero, Marta Montpeyó, Marta Martínez‐Vicente
Cells (2020) Vol. 9, Iss. 11, pp. 2399-2399
Open Access | Times Cited: 102
The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
G. Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 34-44
Closed Access | Times Cited: 93
G. Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 34-44
Closed Access | Times Cited: 93
Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions
Zachary A. Sorrentino, N. Vijayaraghavan, Kimberly-Marie M. Gorion, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 49, pp. 18914-18932
Open Access | Times Cited: 85
Zachary A. Sorrentino, N. Vijayaraghavan, Kimberly-Marie M. Gorion, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 49, pp. 18914-18932
Open Access | Times Cited: 85
Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics
Daniel Savitt, Joseph Jankovic
Drugs (2019) Vol. 79, Iss. 8, pp. 797-810
Closed Access | Times Cited: 83
Daniel Savitt, Joseph Jankovic
Drugs (2019) Vol. 79, Iss. 8, pp. 797-810
Closed Access | Times Cited: 83
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
Meixiang Huang, Erica Modeste, Eric B. Dammer, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Meixiang Huang, Erica Modeste, Eric B. Dammer, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Rescue of α-synuclein aggregation in Parkinson’s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking
Iva Stojkovska, Willayat Yousuf Wani, Friederike Zunke, et al.
Neuron (2021) Vol. 110, Iss. 3, pp. 436-451.e11
Open Access | Times Cited: 69
Iva Stojkovska, Willayat Yousuf Wani, Friederike Zunke, et al.
Neuron (2021) Vol. 110, Iss. 3, pp. 436-451.e11
Open Access | Times Cited: 69
Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 69
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 69
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl, Gagandeep Kaur, Ovidiu Frăţilă, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Tapan Behl, Gagandeep Kaur, Ovidiu Frăţilă, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 66
LRRK2 recruitment, activity, and function in organelles
Luis Bonet‐Ponce, Mark Cookson
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 6871-6890
Open Access | Times Cited: 60
Luis Bonet‐Ponce, Mark Cookson
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 6871-6890
Open Access | Times Cited: 60
Ceramide accumulation induces mitophagy and impairs β-oxidation in PINK1 deficiency
Melissa Vos, Marija Dulovic‐Mahlow, Frida Mandik, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 43
Open Access | Times Cited: 58
Melissa Vos, Marija Dulovic‐Mahlow, Frida Mandik, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 43
Open Access | Times Cited: 58
Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
Ying Xue Xie, Nima Naseri, Jasmine A. Fels, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
Ying Xue Xie, Nima Naseri, Jasmine A. Fels, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
The role of lysosomal cathepsins in neurodegeneration: Mechanistic insights, diagnostic potential and therapeutic approaches
Alice Drobny, Susy Prieto Huarcaya, Jan Philipp Dobert, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 7, pp. 119243-119243
Open Access | Times Cited: 53
Alice Drobny, Susy Prieto Huarcaya, Jan Philipp Dobert, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 7, pp. 119243-119243
Open Access | Times Cited: 53